This study, called PACE-70, is looking at how well a tool called the Practical Geriatric Assessment (PGA) can be used in real-world settings for older adults (age 70 and above) with advanced cancer. The PGA is designed to help doctors understand your overall health better, which can lead to fewer side effects from cancer treatments. You would complete the PGA, either on your own or with staff help, and the results would be shared with your medical team. The study also looks at how the PGA might lead to changes in chemotherapy doses. Researchers will also monitor your step counts using a FitBit and body composition from CT scans. The goal is to see if using the PGA can improve care for older adults with cancer.

Study design

This is an observational study aiming to enroll 150 participants. It is not a randomized trial and does not involve a specific phase of drug development.

What's involved

You would complete the Practical Geriatric Assessment (PGA) before or during your initial medical oncology visit. Your step counts will be monitored via FitBit, and body composition will be measured from standard abdominal CT scans.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of the study, PGA implementation, is measured at 14 days after your initial oncology visit.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.